SecBot SecBot
425 ·Filed Oct 30, 2026

PSNL

Personalis, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed17d 9h ago SEC0001193125-26-441631
Rule 425 M&A communications
Actionable Insight • Neutral

The stockholder vote on November 30 is the next key catalyst. Monitor proxy advisory recommendations and any shareholder opposition filings. The deal appears on track with regulatory clearance (HSR) obtained and S-4 effective.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$15.76
T+0 close · Oct 30, 2026 · via day close
Latest settled
+1.21%
T+5 · $15.95 · next T+20 in 14d
Vs SPY
+1.13%
α at T+5
Latest observation
+1.59%
T+9 · FF3 residual α
  1. T+0 · Nov 2 $15.76entry
  2. T+1 · 14d ago −0.06%α −0.36% · $15.75
  3. T+5 · 8d ago +1.21%α +1.13% · $15.95
  4. T+10 · todayOpen
  5. T+20 · in 14d Pending
  6. T+60 · in 2mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Personalis filed a Rule 425 communication urging stockholders to vote FOR the pending acquisition by Tempus AI at the Special Meeting on November 30, 2026. The filing reiterates the deal terms ($16.25 in Tempus Class A common stock per Personalis share, subject to a collar), highlights a 28% premium to the unaffected 30-day VWAP and a 64% premium to the 90-day VWAP, and argues the transaction mitigates standalone execution risk. No new financial terms, revised deal value, or regulatory updates were disclosed.

Key Financial Metrics

Deal Type
merger

Key Facts

  • Special Meeting of Stockholders scheduled for Monday, November 30, 2026 at 12:00pm ET.
  • Merger consideration is $16.25 in Tempus Class A common stock per Personalis share, subject to a collar based on Tempus stock price.
  • If Tempus Stock Price > $48.42, exchange ratio = $16.25 / Tempus Stock Price; if <= $48.42, exchange ratio = 0.3356.
  • Tempus has the right to elect to pay up to 50% of the merger consideration in cash.
  • Filing states a 28% premium to the unaffected 30-day VWAP and a 64% premium to the unaffected 90-day VWAP.
  • Board unanimously recommends voting FOR the merger and conducted a thorough process with other potential buyers.
  • HSR waiting period expired on October 2, 2026; the merger still requires stockholder approval.
  • Registration statement on Form S-4 was declared effective by the SEC on October 21, 2026, and the definitive proxy statement/prospectus was mailed on or about that date.
  • Filing cites a BTIG analyst estimate of a ~$30B+ U.S. MRD market opportunity (permission for quote neither sought nor obtained).

Financial Impact

Deal value not explicitly stated; consideration is $16.25 per share in Tempus stock, subject to collar. Premiums of 28% (30-day VWAP) and 64% (90-day VWAP) are cited.

stock pricedeal consideration

Risk Factors

  • Stockholder approval is required and not guaranteed.
  • The stock component of consideration exposes Personalis shareholders to Tempus stock price fluctuations and the collar mechanism.
  • Filing is promotional in nature; forward-looking statements carry execution and integration risks.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
64% bullish (11 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
425 Filing (Primary)0001193125-26-441631
Document: 0001193125-26-441631-index-headers.html0001193125-26-441631
Document: 0001193125-26-441631-index.html0001193125-26-441631
Document: 0001193125-26-441631.txt0001193125-26-441631

Track record

29 reports on PSNL

Performance horizon

4 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +18.82% at T+60 after the Jul 20, 2026 report. 8 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $15.16 Now $14.80 −2.34% settles Feb 12
  2. Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $15.71 Now $14.80 −5.79% settles Feb 11
  3. Nov 12, 20264d ago 425 Neutral 4/10 Entry $15.86 Now $14.80 −6.68% settles Feb 10
  4. Nov 6, 202610d ago 425 Neutral 3/10 Entry $15.95 Now $14.80 −7.21% settles Feb 5
  5. Nov 4, 202612d ago 8-K Neutral 5/10 Entry $15.55 Now $14.80 −4.82% settles Feb 3
  6. Nov 3, 202613d ago 425 Neutral 3/10 Entry $15.79 Now $14.80 −6.27% settles Feb 2
  7. Oct 30, 202617d ago 425 Neutral 4/10 Viewing Entry $15.76 Now $14.80 −6.09% settles Jan 29
  8. Oct 21, 202626d ago DEFM14A Neutral 5/10 Entry $15.82 Now $14.80 −6.45% settles Jan 20
  9. Oct 20, 202627d ago 425 Neutral 4/10 Entry $15.90 Now $14.80 −6.92% settles Jan 19
  10. Oct 20, 202627d ago 425 Neutral 5/10 Entry $15.90 Now $14.80 −6.92% settles Jan 19
Showing 10 of 29

US Market Status

Market Closed · Opens in 8h 47m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 30, 2026